Those with type 1 diabetes should not be prescribed semaglutide injections, along with anyone who is at a higher risk or has a family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 due to any further increase of risk that could be caused by the injections
| FSA/HSA eligible: Yes Mochi connects eligible patients with an online medical professional to guide them through their weight loss journey
The findings presented here show that semaglutide modulated food preference, reduced food intake, and caused weight loss without decreasing energy expenditure
But as Ive seen while supporting family members on GLP-1 medications, the reality is much more nuancedand much more personal
Svensson J, Lall S, Dickson SL, Bengtsson BA, Rmer J, Ahnfelt-Rnne I, Ohlsson C, Jansson JO
10.1016/j.cbi.2019.02.023 19 ChatzinikitaE.MaridakiM.PalikarasK.KoutsilierisM.PhilippouA